HealthTronics: Investing with HealthTronics

Patients Physicians Investors Contact


	FOR Investors


		Annual Report

		Financial Reports

		Our Board

		Our Charter

		Information Request

		Press Releases

		Quarterly Conference Call

		SEC Filings

		Stock Performance

		Analysts

Investing in HealthTronics
Home : Investing

HealthTronics (NASDAQ: HTRN) is a urological products and services company that offers a comprehensive range of diagnostic and therapeutic solutions to physicians, hospitals, surgery centers and clinics. The company is both a manufacturer and a provider of surgical services to the urology community.

Our product portfolio includes a full line of urology equipment and products including lithotripters, surgical lasers for treatment of BPH, urology imaging tables and anatomical pathology services.

As a service provider, HealthTronics offers the latest technology in lithotripsy services and prostate therapy services including BPH treatments and prostate cancer treatments.

As a share holder or potential investor, you can find everything you need to know about investing in HealthTronics right here. Please use the menu to the left.

HealthTronics, Inc.
Price	3.138	Last Trade	2008-07-24 10:40:24
Change	-.223	Volume	5,900
Day High	3.400	Day Low	3.138
52 Week High	5.330	52 Week Low	2.650
Source: North American Quotations, Inc. (delayed at least 15 min)

Security analysts, portfolio managers and representatives of financial institutions seeking information about the HealthTronics should contact:

Kay DeJong, Executive Assistant
Investor Relations e-mail: info@healthtronics.com
Investor Relations telephone: (888) 948-1970
Investor Relations fax: (512) 314-4305

HealthTronics
1301 S. Capital of Texas Hwy.
Ste. 200B
Attn: Investor Relations
Austin, TX 78746

Media Inquiries
Lisa Carrell, Marketing Communication Specialist
(888) 252-6575

Transfer Agent and Registrar
American Stock Transfer & Trust Company
New York, NY
Shareholder Services:
(800) 937-5449
(212) 936-5100

Statements in this website that are not strictly historical, including statements regarding plans, objective and future financial performance, are “forward-looking” statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Although HealthTronics believes that the expectations reflected in such forward-looking statements are reasonable, no assurance can be given that the expectations will prove to be correct. Factors that could cause actual results to differ materially from HealthTronic’s expectations include, among others, the existence of demand for and acceptance of HealthTronic’s services, the availability of appropriate candidates for acquisition by HealthTronics, regulatory approvals, economic conditions, the impact of competition and pricing, financing efforts and other factors described from time to time in HealthTronic’s periodic filings with the Securities and Exchange Commission.